Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Ferring International Center SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Ferring International Center SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Ferring International Center SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Ferring International Center SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Ferring International Center SA, Medical Devices Deals, 2012 to YTD 2018 10
Ferring International Center SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Ferring International Center SA, Pharmaceuticals & Healthcare, Deal Details 13
Asset Purchase 13
Ferring International Center Acquire Ex-US Vitaros Assets and Rights from Apricus Biosciences 13
Ferring Pharma Acquires Global Rights to Milprosa from Teva Women’s Health 15
Ferring Pharma to Acquire Novel Drug Delivery Technology from CTCBIO 16
Ferring Pharma Acquires Assets from BioSurface Engineering 17
Ferring Pharma Acquires Ddavp from Sanofi 18
Ferring International To Acquire Assets Of Al-Kindi Pharma For US$6 Million 19
Partnerships 20
Enteris BioPharma Enters into Agreement with Ferring Pharma 20
Ferring Pharma and Chinese Academy of Sciences Enter into Agreement 21
LIDDS Enters into Research Agreement with Ferring Pharma 22
Ferring International and Alrise Biosystems Enter into Co-Development Agreement 23
Ferring Pharma Enters into Agreement with CD Investments 24
Ferring Pharma Enters into Partnership with ICF 25
Ferring Pharma Enters into Agreement with Intralytix 26
Ferring International Center Enters into Agreement with Ache Laboratorios Farmaceuticos 27
Ferring Pharma Enters into Co-Development Agreement with Karolinska Institutet 28
Apricus Biosciences Extends Distribution Agreement with Ferring Pharma 29
Ferring Pharma Enters into Co-Development Agreement with Roche 30
Ferring Pharma And Merck Enter Into Agreement With World Health Organization For Anti-Bleeding Drug 31
Licensing Agreements 32
Ferring Pharma Enters into Licensing Agreement with Ligand Pharma 32
Ferring International Enters into Licensing Agreement with Enteris BioPharma 33
Ferring International Enters into Licensing Agreement with IMAB 34
Levo Therapeutics Enters into Licensing Agreement with Ferring Pharma 35
Ferring Pharma Enters into Licensing Agreement with Seikagaku 36
Ferring Pharma Enters into Licensing Agreement with Cosmo Pharma 37
TxCell Enters into Licensing Agreement with Ferring International for Ovasave 38
Acquisition 40
Ferring Pharma Acquires Rebiotix 40
Ferring International Center SA – Key Competitors 41
Ferring International Center SA – Key Employees 42
Ferring International Center SA – Locations And Subsidiaries 43
Head Office 43
Other Locations & Subsidiaries 43
Recent Developments 47
Corporate Communications 47
Oct 02, 2017: Ferring appoints Klaus Dugi as Executive Vice President and Chief Medical Officer 47
May 23, 2017: Ferring commits $10 million to March of Dimes to expand research needed to end preterm birth 48
Apr 03, 2017: Ferring appoints Dominic Moorhead as Executive Vice President and Chief Financial Officer 49
Product News 50
08/23/2017: Rebiotix to Present on RBX2660 at BioCentury’s 24th Annual NewsMakers in the Biotech Industry Conference 50
08/23/2017: Rebiotix to Present on RBX7455 at BioCentury’s 24th Annual NewsMakers in the Biotech Industry Conference 51
02/12/2018: Rebiotix Develops Microbiome Health Index to Identify Indicators for Microbiome Restoration 52
02/06/2017: Rebiotix to Present on RBX7455 at BIO CEO & Investor Conference 53
Product Approvals 54
Mar 15, 2018: Ferring announces positive outcome of European Decentralised Procedure for Testavan, a treatment for men with hypogonadism 54
Clinical Trials 55
Nov 29, 2017: Rebiotix Announces Expansion of Phase 1 Trial of the Companys Oral Capsule Microbiota Product, RBX7455, Following Successful Completion of Initial Study Arms 55
Nov 15, 2017: Rebiotix to Present on its Anti-Bacterial Agent RBX2660 at 29th Annual Piper Jaffray Healthcare Conference 56
Nov 15, 2017: Rebiotix to Present on its Anti-Bacterial Agent RBX7455 at 29th Annual Piper Jaffray Healthcare Conference 57
Oct 16, 2017: New Clinical Data and Microbiome Research from Rebiotix’s Phase 2 Program for RBX2660 Highlighted at the World Congress of Gastroenterology at ACG2017 58
Oct 12, 2017: Rebiotix Announces New RBX2660 Data Including a Novel Microbiome Biomarker Analysis to be Presented at the World Congress of Gastroenterology at ACG2017 59
Oct 04, 2017: Presentations at ID Week 2017 Highlight Clinical Results and Microbiome Analysis of Patients Treated in Rebiotixs RBX2660 Phase 2 Studies 60
Aug 07, 2017: Rebiotix Announces First Patient Enrolled in Phase 3 Clinical Trial of RBX2660 for the Prevention of Recurrent Clostridium difficile Infection 62
Jan 04, 2017: Rebiotix Treats First Patient in Phase 1 Study of RBX7455, an Orally Delivered Broad-Spectrum Non-Frozen Microbiota Capsule for Recurrent Clostridium difficile Infection 63
Appendix 64
Methodology 64
About GlobalData 64
Contact Us 64
Disclaimer 64
Ferring International Center SA, Pharmaceuticals & Healthcare, Key Facts 2
Ferring International Center SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Ferring International Center SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Ferring International Center SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Ferring International Center SA, Deals By Therapy Area, 2012 to YTD 2018 9
Ferring International Center SA, Medical Devices Deals, 2012 to YTD 2018 10
Ferring International Center SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Ferring International Center Acquire Ex-US Vitaros Assets and Rights from Apricus Biosciences 13
Ferring Pharma Acquires Global Rights to Milprosa from Teva Women's Health 15
Ferring Pharma to Acquire Novel Drug Delivery Technology from CTCBIO 16
Ferring Pharma Acquires Assets from BioSurface Engineering 17
Ferring Pharma Acquires Ddavp from Sanofi 18
Ferring International To Acquire Assets Of Al-Kindi Pharma For US$6 Million 19
Enteris BioPharma Enters into Agreement with Ferring Pharma 20
Ferring Pharma and Chinese Academy of Sciences Enter into Agreement 21
LIDDS Enters into Research Agreement with Ferring Pharma 22
Ferring International and Alrise Biosystems Enter into Co-Development Agreement 23
Ferring Pharma Enters into Agreement with CD Investments 24
Ferring Pharma Enters into Partnership with ICF 25
Ferring Pharma Enters into Agreement with Intralytix 26
Ferring International Center Enters into Agreement with Ache Laboratorios Farmaceuticos 27
Ferring Pharma Enters into Co-Development Agreement with Karolinska Institutet 28
Apricus Biosciences Extends Distribution Agreement with Ferring Pharma 29
Ferring Pharma Enters into Co-Development Agreement with Roche 30
Ferring Pharma And Merck Enter Into Agreement With World Health Organization For Anti-Bleeding Drug 31
Ferring Pharma Enters into Licensing Agreement with Ligand Pharma 32
Ferring International Enters into Licensing Agreement with Enteris BioPharma 33
Ferring International Enters into Licensing Agreement with IMAB 34
Levo Therapeutics Enters into Licensing Agreement with Ferring Pharma 35
Ferring Pharma Enters into Licensing Agreement with Seikagaku 36
Ferring Pharma Enters into Licensing Agreement with Cosmo Pharma 37
TxCell Enters into Licensing Agreement with Ferring International for Ovasave 38
Ferring Pharma Acquires Rebiotix 40
Ferring International Center SA, Key Competitors 41
Ferring International Center SA, Key Employees 42
Ferring International Center SA, Other Locations 43
Ferring International Center SA, Subsidiaries 43
List of Figures
Ferring International Center SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Ferring International Center SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Ferring International Center SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Ferring International Center SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Ferring International Center SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Ferring International Center SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Ferring International Center SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Ferring International Center SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Ferring International Center SA, Medical Devices Deals, 2012 to YTD 2018 10